European Biotech industry figures show signs of chronic

under-funding
 

• The Study (42 page report)
   
• European biotechnology: must do bigger - powerpoint presentation by John Hodgson, Director Critical I Limited (Brussels 30th May 2006)
   
• EuropaBio Press release
   
• Bio of Mr. John Hodgson, Director of Critical I
   
• Bio of Dr. Hans Kast, President  President & CEO, BASF
  EuropaBio Chair
   

• Bio of Mr. Johan Vanhemelrijck, EuropaBio Secretary General

  
   

• How Healthy is European Biotech? - Comparative study on biotech in Europe  - Critical I comparative study for EuropaBio - 2005
  
  

For further information, contact:
 

Critical I Limited - John Hodgson
Mobile: +44 7957 367 850
Tel: +44 1223 307544
E-mail: john.hodgson@criticali.net

Adeline Farrelly
Communications Director
EuropaBio
Tel: +32 2 739 1174
Mob: +32 475 93 17 24
Fax: +32 2 735 4960
e-mail: a.farrelly@europabio.org

EuropaBio
Avenue de l'Armée 6
B-1040 Brussels, Belgium
website: http://www.europabio.org